DKSH, the leading Market Expansion Services provider with a focus on Asia, and Malvern Instruments, a UK-based provider of materials and biophysical characterization technology, have expanded their partnership by adding the MicroCal and NanoSight product ranges in six Asian countries.
DKSH Business Unit Technology, a leading Market Expansion Services provider for technology companies, and Malvern Instruments, have expanded their partnership to include the distribution of Malvern’s MicroCal and NanoSight product lines in Malaysia,
the Philippines, Singapore, Taiwan, Thailand and Vietnam.
NanoSight and MicroCal were recently acquired by Malvern. Predominantly for life science applications, the MicroCal range distributed by DKSH includes both differential scanning and isothermal titration calorimetry, while the NanoSight range includes instruments that utilize nanoparticle tracking analysis to characterize nanoparticles from 10 – 2,000 nm in solution.
The systems are integral in the drug and vaccine research and development. Malvern's MicroCal isothermal titration and differential scanning calorimeters provide information on drug binding and protein stability and are used at almost every stage of drug discovery, development and formulation. Malvern’s acquisition of NanoSight has
expanded their range of analytical technologies for determining formulation stability and detecting aggregates within biologic formulations.
“Malvern Instruments has a rapidly expanding portfolio of products for the biopharmaceuticals sector. The addition of MicroCal and NanoSight instruments will have an immediate impact on Malvern’s ability to provide a complete range of instrumentation solutions and support across life science research and development,” commented David Higgs, Head of Marketing at Malvern Instruments.
“Malvern’s additional life sciences instruments strengthen the partnership between both companies. The expanded agreement is exciting for us as it further extends DKSH’s strong portfolio of analytical solutions for customers in pharmaceutical and bio-pharmaceutical markets in South East Asia and Taiwan. Malvern, supported by our regional coverage, will benefit from seamless resource sharing, a single point of contact and faster response times to customers,” commented Hanno Elbraechter, Head Business Unit Technology at DKSH.